Castleark Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-50,010
Closed -$4.18M 354
2024
Q4
$4.18M Sell
50,010
-1,870
-4% -$154K 0.15% 152
2024
Q3
$3.8M Sell
51,880
-1,900
-4% -$143K 0.15% 140
2024
Q2
$3.68M Sell
53,780
-450
-0.8% -$31.2K 0.15% 142
2024
Q1
$3.75M Sell
54,230
-19,570
-27% -$1.35M 0.16% 145
2023
Q4
$5.29M Sell
73,800
-100
-0.1% -$5.75K 0.23% 104
2023
Q3
$3.85M Sell
73,900
-3,390
-4% -$197K 0.2% 126
2023
Q2
$4.89M Buy
77,290
+53,120
+220% +$3.31M 0.22% 108
2023
Q1
$1.31M Sell
24,170
-37,200
-61% -$1.8M 0.06% 179
2022
Q4
$3.25M Sell
61,370
-26,810
-30% -$1.34M 0.17% 133
2022
Q3
$4.1M Sell
88,180
-2,000
-2% -$104K 0.23% 114
2022
Q2
$5.15M Buy
90,180
+49,910
+124% +$2.83M 0.28% 94
2022
Q1
$2.46M Buy
+40,270
New +$2.09M 0.11% 171

Other funds holding ITCI